Literature DB >> 8545290

The effect of nilvadipine on bloodflow in the dorsal pedis artery in type 2 diabetic patients--a study using duplex Doppler ultrasonography.

H Sone1, Y Okuda, M Mizutani, Y Kawakami, C Bannai, K Yamashita.   

Abstract

The effects of nilvadipine on the peripheral circulation in the lower extremities using a duplex system of two-dimensional colour and pulse Doppler ultrasonography were studied in 32 patients with type 2 diabetes mellitus and mild essential hypertension. The patients (19 men and 13 women) were randomly divided into treatment and control groups. The anatomical cross-sectional area and blood flow index of the dorsal pedis artery were determined by colour and pulse Doppler ultrasonography before and 60 min after administration of 4 mg nilvadipine or placebo. Pulse rate and blood pressure were measured simultaneously. There were no significant changes in pulse rate or blood pressure after administration of either drug. Both cross-sectional areas (from 4.3 +/- 0.4 to 5.2 +/- 0.5 mm2, p < 0.05) and blood flow index (from 40.3 +/- 4.3 to 58.8 +/- 9.0, p < 0.05) were significantly increased in the treatment group, whereas there were no significant changes in either measurement in the control group. The findings showed that a single administration of nilvadipine increases blood flow in the dorsal pedis arteries of diabetic patients.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8545290      PMCID: PMC2398257          DOI: 10.1136/pgmj.71.840.613

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  7 in total

1.  Intermittent claudication--be conservative.

Authors:  J D Coffman
Journal:  N Engl J Med       Date:  1991-08-22       Impact factor: 91.245

2.  A new instrument for continuous measurement of tissue blood flow by light beating spectroscopy.

Authors:  G E Nilsson; T Tenland; P A Obert
Journal:  IEEE Trans Biomed Eng       Date:  1980-01       Impact factor: 4.538

Review 3.  Sorbitol, phosphoinositides, and sodium-potassium-ATPase in the pathogenesis of diabetic complications.

Authors:  D A Greene; S A Lattimer; A A Sima
Journal:  N Engl J Med       Date:  1987-03-05       Impact factor: 91.245

4.  Pharmacokinetics of nilvadipine in healthy volunteers.

Authors:  M Terakawa; Y Tokuma; A Shishido; H Noguchi
Journal:  J Clin Pharmacol       Date:  1987-02       Impact factor: 3.126

5.  The effect of nilvadipine, a dihydropyridine type calcium channel blocker, on local cerebral blood flow in rats.

Authors:  Y Furuichi; S Takakura; H Satoh; J Mori; M Kohsaka
Journal:  Jpn J Pharmacol       Date:  1992-04

6.  Comparison of the cardiovascular effect of FR34235, a new dihydropyridine, with other calcium antagonists.

Authors:  M Ohtsuka; T Ono; J Hiroi; K Esumi; H Kikuchi; S Kumada
Journal:  J Cardiovasc Pharmacol       Date:  1983 Nov-Dec       Impact factor: 3.105

7.  Pathogenesis of diabetic neuropathy.

Authors:  P C Johnson; S C Doll; D W Cromey
Journal:  Ann Neurol       Date:  1986-05       Impact factor: 10.422

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.